Clinical trials: Chronic Diabetic Macular Edema
- Condition Chronic Diabetic Macular Edema
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Chronic Diabetic Macular Oedema Considered Insufficiently Responsive to Available Therapies
Iluvien Registry Safety Study
The study will include any patient treated with Iluvien at designated sites in European countries where marketing authorization has been granted in order to obtain broader safety and usage information.
- Trial name
- IRISS (NCT01998412)
- Where
- United States
- Volunteers
- 559 people
- Sponsor
- Alimera Sciences